BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2142698)

  • 1. High-affinity platelet [3H]LSD binding is decreased in panic disorder.
    Norman TR; Judd FK; Staikos V; Burrows GD; McIntyre IM
    J Affect Disord; 1990 Jun; 19(2):119-23. PubMed ID: 2142698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet serotonin uptake and 3H-imipramine binding in panic disorder.
    Norman TR; Sartor DM; Judd FK; Burrows GD; Gregory MS; McIntyre IM
    J Affect Disord; 1989; 17(1):77-81. PubMed ID: 2544638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet 3H-rauwolscine binding in patients with panic attacks.
    Norman TR; Kimber NM; Judd FK; Burrows GD; McIntyre IM
    Psychiatry Res; 1987 Sep; 22(1):43-8. PubMed ID: 2821567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet serotonin uptake in panic disorder.
    Norman TR; Judd FK; Gregory M; James RH; Kimber NM; McIntyre IM; Burrows GD
    J Affect Disord; 1986; 11(1):69-72. PubMed ID: 2944930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
    Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM
    Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
    Arora RC; Meltzer HY
    Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet serotonin uptake in panic disorder patients: a replication study.
    Norman TR; Judd FK; Burrows GD; McIntyre IM
    Psychiatry Res; 1989 Oct; 30(1):63-8. PubMed ID: 2594872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet binding studies in panic disorder.
    Nutt DJ; Fraser S
    J Affect Disord; 1987; 12(1):7-11. PubMed ID: 3033042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
    Schneider LS; Munjack D; Severson JA; Palmer R
    Biol Psychiatry; 1987 Jan; 22(1):59-66. PubMed ID: 3790641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet [3H]imipramine binding in patients with panic disorder.
    Uhde TW; Berrettini WH; Roy-Byrne PP; Boulenger JP; Post RM
    Biol Psychiatry; 1987 Jan; 22(1):52-8. PubMed ID: 3790640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
    Spigset O; Mjörndal T
    Neuropsychopharmacology; 1997 Apr; 16(4):285-93. PubMed ID: 9094146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tritiated imipramine binding to platelets is decreased in patients with agoraphobia.
    Lewis DA; Noyes R; Coryell W; Clancy J
    Psychiatry Res; 1985 Sep; 16(1):1-9. PubMed ID: 2997822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa.
    Spigset O; Andersen T; Hägg S; Mjöndal T
    Eur Neuropsychopharmacol; 1999 Dec; 9(6):469-73. PubMed ID: 10625113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
    Spigset O; Mjörndal T
    Psychopharmacology (Berl); 1997 Sep; 133(1):39-42. PubMed ID: 9335078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase activity in patients with panic disorder.
    Gorman J; Liebowitz MR; Fyer AJ; Levitt M; Baron M; Davies S; Klein DF
    Biol Psychiatry; 1985 Aug; 20(8):852-7. PubMed ID: 4027301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin uptake in panic disorder and agoraphobia.
    Pecknold JC; Suranyi-Cadotte B; Chang H; Nair NP
    Neuropsychopharmacology; 1988 May; 1(2):173-6. PubMed ID: 3251498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.